Several preclinical studies show that the impaired insulinotropic action of GIP under conditions of hyperglycemia is paralleled by decreased expression of the GIP receptor (Gipr) in pancreatic islets [[164], [165], [166]]. This evidence concerns the gene GIPR and Hyperglycemia.